NEWPORT BEACH, CA–(Marketwired – Feb 21, 2017) – ADVANTIS CORPORATION (OTC PINK: ADVT) begins distribution of topical cannabis roll-on and Tinctures to treat pain conditions.
Advantis Corp has been developing innovative products for the treatment of pain conditions since hiring their CEO, Christopher Swartz. Mr. Swartz has been involved in alternative and conventional treatments for pain for over 12 years and has worked in consulting rolls with some of the largest companies in the country. He stated, “We have seen the problem with chronic pain conditions increase exponentially and with that, opiate misuse and addiction as well. I have personally seen all this happen and have observed (too many times) people whom have lost hope.” Mr. Swartz further explained, “I have been passionate about creating solutions to effectively treat the masses without the negative side effects associated with opioids. Elixcure is the answer, and we are excited beyond belief to share this remedy with everyone